J Jay Lobell's Net Worth

$3.99 Million

Estimate Recalculated Jul 15, 2024 03:07PM EST

Who is J Jay Lobell?

J Jay Lobell has an estimated net worth of $3.99 Million. This is based on reported shares across multiple companies, which include CHEM RX CORP, CytRx Oncology Corp, NORTON SOUND ACQUISITION CORP., SITKA SCIENCES, INC., PARDES BIOSCIENCES, INC., Fortress Biotech, Inc., MANHATTAN PHARMACEUTICALS INC, NOVADEL PHARMA INC, Hana Biosciences Inc, KERYX BIOPHARMACEUTICALS INC, and DENALI SCIENCES, INC..

SEC CIK

J Jay Lobell's CIK is 0001172659

Past Insider Trading and Trends

2007 was J Jay Lobell's most active year for acquiring shares with 21 total transactions. J Jay Lobell's most active month to acquire stocks was the month of December. 2023 was J Jay Lobell's most active year for disposing of shares, totalling 5 transactions. J Jay Lobell's most active month to dispose stocks was the month of July. 2023 saw J Jay Lobell paying a total of $249,999.84 for 436,901 shares, this is the most they've acquired in one year. In 2022 J Jay Lobell cashed out on 3,591,265 shares for a total of $0.00, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

CHEM RX CORP No price found

CEO and Secretary

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+3.37%
10.96K
—
—
336.42K
Jan 16
Form 4
+0.31%
1.02K
—
—
325.46K
Oct 16
Form 4
+0.15%
496
—
—
324.44K
Jul 16
Form 4
+0.15%
481
—
—
323.95K
Apr 16
Form 4
+1.48%
4.72K
—
—
323.47K
Jan 24
Form 4
—
0
—
—
0
Scheduled
Feb 23
Form 4
—
0
—
—
0
Scheduled
Feb 21
Form 4
—
0
—
—
0
Scheduled
Feb 16 - Feb 20
Form 4
—
0
—
—
0
Scheduled
Feb 13 - Feb 14
Form 4
—
0
—
—
0
Scheduled
Feb 9 - Feb 12
Form 4
—
0
—
—
0
Scheduled
Feb 6 - Feb 7
Form 4
—
0
—
—
0
Scheduled
Feb 2 - Feb 5
Form 4
—
0
—
—
0
Scheduled
Jan 31
Form 4
—
0
—
—
0
Scheduled
Jan 29 - Jan 30
Form 4
—
0
—
—
0
Scheduled
Jan 25
Form 4
—
0
—
—
0
Jan 24
Form 4
—
0
—
—
0
Jan 17 - Jan 18
Form 4
—
0
—
—
0
Jan 11 - Jan 12
Form 3
—
0
—
—
0
No matching records found

CytRx Oncology Corp No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-162.67K
—
—
0
Sep 19
Form 4
—
0
—
—
0
Aug 8
Form 3
—
0
—
—
0
No matching records found

NORTON SOUND ACQUISITION CORP. No price found

President and Secretary

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Form 3
—
0
—
—
0
No matching records found

SITKA SCIENCES, INC. No price found

President and Secretary

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Form 3
—
0
—
—
0
No matching records found

PARDES BIOSCIENCES, INC. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-1.36M
—
—
0
Aug 31
Form 4
—
0
—
—
0
Jun 1
Form 4
-62.02%
-2.23M
—
—
1.36M
Jul 19
Form 4
—
0
—
—
0
Jun 8
Form 4
—
0
—
—
0
Dec 23
Form 3
—
0
—
—
0
No matching records found